3D Signatures approached us pre-IPO to develop a consistent brand strategy, identity and presentation prior to listing. Their vision? To change the way that cancer treatment plans are developed by using genomic imaging. We looked at the entire patient journey from diagnosis to treatment, and identified the kernel in why they were a game-changer—the power of early diagnosis and targeted can save lives, and give people a better quality of life—all through an integral piece of our chromosomes.
Identity / Website / Collateral / Presentation